|Articles|February 15, 2022
Supplements and Featured Publications
- Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)
Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)
Advertisement
Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease that has no established cure and is frequently fatal within 2 to 5 years as patients experience a rapid functional decline in their abilities to move, talk, swallow, and breathe. Current treatment options remain limited, but there is a pipeline of late-stage therapeutic options that could expand the treatment options for patients with ALS.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
2
Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk
3
US Employer Health Care Costs Projected to Rise 9.5% in 2027
4
MRI Shows Hypothalamic Atrophy in Narcolepsy Type 1, Sparing Subregion
5

